U.S. microbiome health startup Verb Biotics and Israeli computational biology company Evogene have entered a collaboration agreement to develop new probiotic strains that produce microbial metabolites with advanced properties for precision health.
U.S. microbiome health startup Verb Biotics and Israeli computational biology company Evogene have entered a collaboration agreement to develop new probiotic strains that produce microbial metabolites with advanced properties for precision health.
/PRNewswire/ Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development.
Probiotic R&D continues to flourish. Supplement brands stand to benefit as new strains backed by emerging science are targeting at least six separate health concerns including digestive health, immunity, oral health, mood, women's health and sports.